Offer - Urjas Oil for just ₹ 1 X
Cepodem XP 100 Dry Suspention, a prescription drug, is manufactured in various forms such as Syrup. The alternative uses of Cepodem XP 100 Dry Suspention have also been explained below.
The correct dosage of Cepodem XP 100 Dry Suspention depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Cepodem XP 100 Dry Suspention have been listed ahead. Normally, these side effects of Cepodem XP 100 Dry Suspention are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Cepodem XP 100 Dry Suspention is Mild for pregnant women and Moderate for women who are breastfeeding. In addition, Cepodem XP 100 Dry Suspention's effects on the liver, heart and kidney are discussed below in the Cepodem XP 100 Dry Suspention related warnings section.
Cepodem XP 100 Dry Suspention is not recommended if you suffer from certain medical conditions as it can have adverse effects. Jaundice are examples of such conditions. Other contraindications of Cepodem XP 100 Dry Suspention have been discussed in the sections ahead.
Drug reaction of Cepodem XP 100 Dry Suspention with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Cepodem XP 100 Dry Suspention is safe while driving, and is addiction.
Cepodem XP 100 Dry Suspention is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Cepodem XP 100 Dry Suspention safe for pregnant women?
Cepodem Xp has mild to no side effects in pregnant women.
Is the use of Cepodem XP 100 Dry Suspention safe during breastfeeding?
Cepodem Xp may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Cepodem Xp, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Cepodem Xp.
What is the effect of Cepodem XP 100 Dry Suspention on the Kidneys?
Cepodem Xp may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Cepodem XP 100 Dry Suspention on the Liver?
Cepodem Xp can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Cepodem XP 100 Dry Suspention on the Heart?
Cepodem Xp has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Cepodem XP 100 Dry Suspention unless your doctor advises you to do so -
Is this Cepodem XP 100 Dry Suspention habit forming or addictive?
No, you will not get addicted to Cepodem XP 100 Dry Suspention.
Interaction between Food and Cepodem XP 100 Dry Suspention
It is safe to take Cepodem XP 100 Dry Suspention with food.
Interaction between Alcohol and Cepodem XP 100 Dry Suspention
It is difficult to say anything about the effect of Cepodem XP 100 Dry Suspention and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311